Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model

Phospholipid vesicles encapsulating Hb (Hb-vesicles: HbV) have been developed for use as artificial O 2 carriers (250 nm φ). As one of the safety evaluations, we analyzed the influence of HbV on the organ functions by laboratory tests of plasma on a total of 29 analytes. The HbV suspension ([Hb]=10...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomaterials 2004-08, Vol.25 (18), p.4317-4325
Hauptverfasser: Sakai, Hiromi, Horinouchi, Hirohisa, Masada, Yohei, Takeoka, Shinji, Ikeda, Eiji, Takaori, Masuhiko, Kobayashi, Koichi, Tsuchida, Eishun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4325
container_issue 18
container_start_page 4317
container_title Biomaterials
container_volume 25
creator Sakai, Hiromi
Horinouchi, Hirohisa
Masada, Yohei
Takeoka, Shinji
Ikeda, Eiji
Takaori, Masuhiko
Kobayashi, Koichi
Tsuchida, Eishun
description Phospholipid vesicles encapsulating Hb (Hb-vesicles: HbV) have been developed for use as artificial O 2 carriers (250 nm φ). As one of the safety evaluations, we analyzed the influence of HbV on the organ functions by laboratory tests of plasma on a total of 29 analytes. The HbV suspension ([Hb]=10 g/dl) was intravenously infused into male Wistar rats (20 ml/kg; whole blood = 56 ml/kg). The blood was withdrawn at 8 h, and 1, 2, 3, and 7 days after infusion, and the plasma was ultracentrifuged to remove HbV in order to avoid its interference effect on the analytes. Enzyme concentrations, AST, ALT, ALP, and LAP showed significant, but minor changes, and did not show a sign of a deteriorative damage to the liver that was one of the main organs for the HbV entrapment and the succeeding metabolism. The amylase and lipase activities showed reversible changes, however, there was no morphological changes in pancreas. Plasma bilirubin and iron did not increase in spite of the fact that a large amount of Hb was metabolized in the macrophages. Cholesterols, phospholipids, and β-lipoprotein transiently increased showing the maximum at 1 or 2 days, and returned to the control level at 7 days. They should be derived from the membrane components of HbV that are liberated from macrophages entrapping HbV. Together with the previous report of the prompt metabolism of HbV in the reticuloendothelial system by histopathological examination, it can be concluded that HbV infusion transiently modified the values of the analytes without any irreversible damage to the corresponding organs at the bolus infusion rate of 20 ml/kg.
doi_str_mv 10.1016/j.biomaterials.2003.11.005
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71764342</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0142961203010706</els_id><sourcerecordid>17819650</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-ece7cda33e4cc43ee51dd145f8f74800af71775462e6da4a0bae92807c1f6dc3</originalsourceid><addsrcrecordid>eNqNkc1u3CAURlHVqpmkfYUKdVE1CzuAwcbdRelPKiXqJnuE4TJhZEMKOGrePoxmpHaXrhBwPj50D0IfKWkpof3Frp18XHSB5PWcW0ZI11LaEiJeoQ2Vg2zESMRrtCGUs2bsKTtBpznvSN0Tzt6iEyoI70fGNqjcQtFTnH1ecHT4Hpa4nePkQ_MI2ZsZMv6sU_HOm1qG45-nLQRsdEoeUj7HOlhc7sEn7IObVwgGcAw4pq0O2K3BFB9DrpdY46QLXqKF-R164-rP4f1xPUN337_dXV03N79-_Ly6vGkM72RpwMBgrO464KaeAAhqLeXCSTdwSYh2Ax0GwXsGvdVck0nDyCQZDHW9Nd0Z-nR49iHF3yvkohafDcyzDhDXrGq65x1nL4JMMkGk7F4E6SDp2AtSwS8H0KSYcwKnHpJfdHpSlKi9RLVT_0pUe4mKUlUl1vCHY8s6LWD_Ro_WKvD1AEAd3mMVobLx-9Fbn8AUZaP_n55nStq2vw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17819650</pqid></control><display><type>article</type><title>Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Sakai, Hiromi ; Horinouchi, Hirohisa ; Masada, Yohei ; Takeoka, Shinji ; Ikeda, Eiji ; Takaori, Masuhiko ; Kobayashi, Koichi ; Tsuchida, Eishun</creator><creatorcontrib>Sakai, Hiromi ; Horinouchi, Hirohisa ; Masada, Yohei ; Takeoka, Shinji ; Ikeda, Eiji ; Takaori, Masuhiko ; Kobayashi, Koichi ; Tsuchida, Eishun</creatorcontrib><description>Phospholipid vesicles encapsulating Hb (Hb-vesicles: HbV) have been developed for use as artificial O 2 carriers (250 nm φ). As one of the safety evaluations, we analyzed the influence of HbV on the organ functions by laboratory tests of plasma on a total of 29 analytes. The HbV suspension ([Hb]=10 g/dl) was intravenously infused into male Wistar rats (20 ml/kg; whole blood = 56 ml/kg). The blood was withdrawn at 8 h, and 1, 2, 3, and 7 days after infusion, and the plasma was ultracentrifuged to remove HbV in order to avoid its interference effect on the analytes. Enzyme concentrations, AST, ALT, ALP, and LAP showed significant, but minor changes, and did not show a sign of a deteriorative damage to the liver that was one of the main organs for the HbV entrapment and the succeeding metabolism. The amylase and lipase activities showed reversible changes, however, there was no morphological changes in pancreas. Plasma bilirubin and iron did not increase in spite of the fact that a large amount of Hb was metabolized in the macrophages. Cholesterols, phospholipids, and β-lipoprotein transiently increased showing the maximum at 1 or 2 days, and returned to the control level at 7 days. They should be derived from the membrane components of HbV that are liberated from macrophages entrapping HbV. Together with the previous report of the prompt metabolism of HbV in the reticuloendothelial system by histopathological examination, it can be concluded that HbV infusion transiently modified the values of the analytes without any irreversible damage to the corresponding organs at the bolus infusion rate of 20 ml/kg.</description><identifier>ISSN: 0142-9612</identifier><identifier>EISSN: 1878-5905</identifier><identifier>DOI: 10.1016/j.biomaterials.2003.11.005</identifier><identifier>PMID: 15046922</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Animals ; Biomimetic material ; Blood ; Blood Substitutes - administration &amp; dosage ; Blood Substitutes - chemistry ; Blood Substitutes - pharmacokinetics ; Drug Carriers - administration &amp; dosage ; Drug Carriers - chemistry ; Drug delivery ; Drug Delivery Systems - methods ; Hemoglobins - administration &amp; dosage ; Hemoglobins - chemistry ; Hepatitis B virus ; In vivo test ; Injections, Intravenous ; Liposome ; Liposomes - administration &amp; dosage ; Liposomes - chemistry ; Liposomes - pharmacokinetics ; Liver - drug effects ; Liver - metabolism ; Male ; Metabolic Clearance Rate ; Nanoparticle ; Organ Specificity ; Oxygen - metabolism ; Pancreas - cytology ; Pancreas - drug effects ; Pancreas - metabolism ; Rats ; Rats, Wistar</subject><ispartof>Biomaterials, 2004-08, Vol.25 (18), p.4317-4325</ispartof><rights>2003 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-ece7cda33e4cc43ee51dd145f8f74800af71775462e6da4a0bae92807c1f6dc3</citedby><cites>FETCH-LOGICAL-c438t-ece7cda33e4cc43ee51dd145f8f74800af71775462e6da4a0bae92807c1f6dc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0142961203010706$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15046922$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sakai, Hiromi</creatorcontrib><creatorcontrib>Horinouchi, Hirohisa</creatorcontrib><creatorcontrib>Masada, Yohei</creatorcontrib><creatorcontrib>Takeoka, Shinji</creatorcontrib><creatorcontrib>Ikeda, Eiji</creatorcontrib><creatorcontrib>Takaori, Masuhiko</creatorcontrib><creatorcontrib>Kobayashi, Koichi</creatorcontrib><creatorcontrib>Tsuchida, Eishun</creatorcontrib><title>Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model</title><title>Biomaterials</title><addtitle>Biomaterials</addtitle><description>Phospholipid vesicles encapsulating Hb (Hb-vesicles: HbV) have been developed for use as artificial O 2 carriers (250 nm φ). As one of the safety evaluations, we analyzed the influence of HbV on the organ functions by laboratory tests of plasma on a total of 29 analytes. The HbV suspension ([Hb]=10 g/dl) was intravenously infused into male Wistar rats (20 ml/kg; whole blood = 56 ml/kg). The blood was withdrawn at 8 h, and 1, 2, 3, and 7 days after infusion, and the plasma was ultracentrifuged to remove HbV in order to avoid its interference effect on the analytes. Enzyme concentrations, AST, ALT, ALP, and LAP showed significant, but minor changes, and did not show a sign of a deteriorative damage to the liver that was one of the main organs for the HbV entrapment and the succeeding metabolism. The amylase and lipase activities showed reversible changes, however, there was no morphological changes in pancreas. Plasma bilirubin and iron did not increase in spite of the fact that a large amount of Hb was metabolized in the macrophages. Cholesterols, phospholipids, and β-lipoprotein transiently increased showing the maximum at 1 or 2 days, and returned to the control level at 7 days. They should be derived from the membrane components of HbV that are liberated from macrophages entrapping HbV. Together with the previous report of the prompt metabolism of HbV in the reticuloendothelial system by histopathological examination, it can be concluded that HbV infusion transiently modified the values of the analytes without any irreversible damage to the corresponding organs at the bolus infusion rate of 20 ml/kg.</description><subject>Animals</subject><subject>Biomimetic material</subject><subject>Blood</subject><subject>Blood Substitutes - administration &amp; dosage</subject><subject>Blood Substitutes - chemistry</subject><subject>Blood Substitutes - pharmacokinetics</subject><subject>Drug Carriers - administration &amp; dosage</subject><subject>Drug Carriers - chemistry</subject><subject>Drug delivery</subject><subject>Drug Delivery Systems - methods</subject><subject>Hemoglobins - administration &amp; dosage</subject><subject>Hemoglobins - chemistry</subject><subject>Hepatitis B virus</subject><subject>In vivo test</subject><subject>Injections, Intravenous</subject><subject>Liposome</subject><subject>Liposomes - administration &amp; dosage</subject><subject>Liposomes - chemistry</subject><subject>Liposomes - pharmacokinetics</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Male</subject><subject>Metabolic Clearance Rate</subject><subject>Nanoparticle</subject><subject>Organ Specificity</subject><subject>Oxygen - metabolism</subject><subject>Pancreas - cytology</subject><subject>Pancreas - drug effects</subject><subject>Pancreas - metabolism</subject><subject>Rats</subject><subject>Rats, Wistar</subject><issn>0142-9612</issn><issn>1878-5905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u3CAURlHVqpmkfYUKdVE1CzuAwcbdRelPKiXqJnuE4TJhZEMKOGrePoxmpHaXrhBwPj50D0IfKWkpof3Frp18XHSB5PWcW0ZI11LaEiJeoQ2Vg2zESMRrtCGUs2bsKTtBpznvSN0Tzt6iEyoI70fGNqjcQtFTnH1ecHT4Hpa4nePkQ_MI2ZsZMv6sU_HOm1qG45-nLQRsdEoeUj7HOlhc7sEn7IObVwgGcAw4pq0O2K3BFB9DrpdY46QLXqKF-R164-rP4f1xPUN337_dXV03N79-_Ly6vGkM72RpwMBgrO464KaeAAhqLeXCSTdwSYh2Ax0GwXsGvdVck0nDyCQZDHW9Nd0Z-nR49iHF3yvkohafDcyzDhDXrGq65x1nL4JMMkGk7F4E6SDp2AtSwS8H0KSYcwKnHpJfdHpSlKi9RLVT_0pUe4mKUlUl1vCHY8s6LWD_Ro_WKvD1AEAd3mMVobLx-9Fbn8AUZaP_n55nStq2vw</recordid><startdate>20040801</startdate><enddate>20040801</enddate><creator>Sakai, Hiromi</creator><creator>Horinouchi, Hirohisa</creator><creator>Masada, Yohei</creator><creator>Takeoka, Shinji</creator><creator>Ikeda, Eiji</creator><creator>Takaori, Masuhiko</creator><creator>Kobayashi, Koichi</creator><creator>Tsuchida, Eishun</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>F28</scope><scope>7X8</scope></search><sort><creationdate>20040801</creationdate><title>Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model</title><author>Sakai, Hiromi ; Horinouchi, Hirohisa ; Masada, Yohei ; Takeoka, Shinji ; Ikeda, Eiji ; Takaori, Masuhiko ; Kobayashi, Koichi ; Tsuchida, Eishun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-ece7cda33e4cc43ee51dd145f8f74800af71775462e6da4a0bae92807c1f6dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Biomimetic material</topic><topic>Blood</topic><topic>Blood Substitutes - administration &amp; dosage</topic><topic>Blood Substitutes - chemistry</topic><topic>Blood Substitutes - pharmacokinetics</topic><topic>Drug Carriers - administration &amp; dosage</topic><topic>Drug Carriers - chemistry</topic><topic>Drug delivery</topic><topic>Drug Delivery Systems - methods</topic><topic>Hemoglobins - administration &amp; dosage</topic><topic>Hemoglobins - chemistry</topic><topic>Hepatitis B virus</topic><topic>In vivo test</topic><topic>Injections, Intravenous</topic><topic>Liposome</topic><topic>Liposomes - administration &amp; dosage</topic><topic>Liposomes - chemistry</topic><topic>Liposomes - pharmacokinetics</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Male</topic><topic>Metabolic Clearance Rate</topic><topic>Nanoparticle</topic><topic>Organ Specificity</topic><topic>Oxygen - metabolism</topic><topic>Pancreas - cytology</topic><topic>Pancreas - drug effects</topic><topic>Pancreas - metabolism</topic><topic>Rats</topic><topic>Rats, Wistar</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sakai, Hiromi</creatorcontrib><creatorcontrib>Horinouchi, Hirohisa</creatorcontrib><creatorcontrib>Masada, Yohei</creatorcontrib><creatorcontrib>Takeoka, Shinji</creatorcontrib><creatorcontrib>Ikeda, Eiji</creatorcontrib><creatorcontrib>Takaori, Masuhiko</creatorcontrib><creatorcontrib>Kobayashi, Koichi</creatorcontrib><creatorcontrib>Tsuchida, Eishun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ANTE: Abstracts in New Technology &amp; Engineering</collection><collection>MEDLINE - Academic</collection><jtitle>Biomaterials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sakai, Hiromi</au><au>Horinouchi, Hirohisa</au><au>Masada, Yohei</au><au>Takeoka, Shinji</au><au>Ikeda, Eiji</au><au>Takaori, Masuhiko</au><au>Kobayashi, Koichi</au><au>Tsuchida, Eishun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model</atitle><jtitle>Biomaterials</jtitle><addtitle>Biomaterials</addtitle><date>2004-08-01</date><risdate>2004</risdate><volume>25</volume><issue>18</issue><spage>4317</spage><epage>4325</epage><pages>4317-4325</pages><issn>0142-9612</issn><eissn>1878-5905</eissn><abstract>Phospholipid vesicles encapsulating Hb (Hb-vesicles: HbV) have been developed for use as artificial O 2 carriers (250 nm φ). As one of the safety evaluations, we analyzed the influence of HbV on the organ functions by laboratory tests of plasma on a total of 29 analytes. The HbV suspension ([Hb]=10 g/dl) was intravenously infused into male Wistar rats (20 ml/kg; whole blood = 56 ml/kg). The blood was withdrawn at 8 h, and 1, 2, 3, and 7 days after infusion, and the plasma was ultracentrifuged to remove HbV in order to avoid its interference effect on the analytes. Enzyme concentrations, AST, ALT, ALP, and LAP showed significant, but minor changes, and did not show a sign of a deteriorative damage to the liver that was one of the main organs for the HbV entrapment and the succeeding metabolism. The amylase and lipase activities showed reversible changes, however, there was no morphological changes in pancreas. Plasma bilirubin and iron did not increase in spite of the fact that a large amount of Hb was metabolized in the macrophages. Cholesterols, phospholipids, and β-lipoprotein transiently increased showing the maximum at 1 or 2 days, and returned to the control level at 7 days. They should be derived from the membrane components of HbV that are liberated from macrophages entrapping HbV. Together with the previous report of the prompt metabolism of HbV in the reticuloendothelial system by histopathological examination, it can be concluded that HbV infusion transiently modified the values of the analytes without any irreversible damage to the corresponding organs at the bolus infusion rate of 20 ml/kg.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>15046922</pmid><doi>10.1016/j.biomaterials.2003.11.005</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0142-9612
ispartof Biomaterials, 2004-08, Vol.25 (18), p.4317-4325
issn 0142-9612
1878-5905
language eng
recordid cdi_proquest_miscellaneous_71764342
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Biomimetic material
Blood
Blood Substitutes - administration & dosage
Blood Substitutes - chemistry
Blood Substitutes - pharmacokinetics
Drug Carriers - administration & dosage
Drug Carriers - chemistry
Drug delivery
Drug Delivery Systems - methods
Hemoglobins - administration & dosage
Hemoglobins - chemistry
Hepatitis B virus
In vivo test
Injections, Intravenous
Liposome
Liposomes - administration & dosage
Liposomes - chemistry
Liposomes - pharmacokinetics
Liver - drug effects
Liver - metabolism
Male
Metabolic Clearance Rate
Nanoparticle
Organ Specificity
Oxygen - metabolism
Pancreas - cytology
Pancreas - drug effects
Pancreas - metabolism
Rats
Rats, Wistar
title Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T02%3A09%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolism%20of%20hemoglobin-vesicles%20(artificial%20oxygen%20carriers)%20and%20their%20influence%20on%20organ%20functions%20in%20a%20rat%20model&rft.jtitle=Biomaterials&rft.au=Sakai,%20Hiromi&rft.date=2004-08-01&rft.volume=25&rft.issue=18&rft.spage=4317&rft.epage=4325&rft.pages=4317-4325&rft.issn=0142-9612&rft.eissn=1878-5905&rft_id=info:doi/10.1016/j.biomaterials.2003.11.005&rft_dat=%3Cproquest_cross%3E17819650%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17819650&rft_id=info:pmid/15046922&rft_els_id=S0142961203010706&rfr_iscdi=true